By: Elaine Schattner From: forbes.com If there’s one message I’d take home from the annual meeting of the American Society of Hematology (ASH) in Orlando, concerning blood cancers – like leukemia, lymphoma and multiple myeloma – it’s that there are a lot of new drugs for doctors and patients to know about, consider and possibly try. If I had to …